Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Ofurace-d6 | 2-Chloro-N-(2,6-dimethylphenyl)-N-(tetrahydro-2-oxo-3-furanyl)acetamide-d6; 3-(N-Chloracetyl-N-2,6-dimethylphenylamino)-γ-butyrolactone-d6; Milfuram-d6; Ortho 20615-d6; RE 20615-d6; | unlabelled: 58810-48-3 | C14H10D6ClNO3 | 287.77 | 2-Chloro-N-(2,6-dimethylphenyl)-N-(tetrahydro-2-oxo-3-furanyl)acetamide-d6; 3-(N-Chloracetyl-N-2,6-dimethylphenylamino)-γ-butyrolactone-d6; Milfuram-... |
| OG-L002 | 4-[(1R,2S)-2-Aminocyclopropyl]-[1,1-biphenyl]-3-ol; 4-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-ol | 1357302-64-7 | C15H15NO | 225.29 | 4-[(1R,2S)-2-Aminocyclopropyl]-[1,1-biphenyl]-3-ol; 4-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-ol
|
| OGT 2115 | 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propen-1-yl]amino]-3-fluorophenyl]-5-benzoxazoleacetic Acid; 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic Acid; | 853929-59-6 | C24H16BrFN2O4 | 495.3 | 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propen-1-yl]amino]-3-fluorophenyl]-5-benzoxazoleacetic Acid; 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluor... |
| 8-OH-DPAT | (±)-7-(Dipropylamino)-5,6,7,8-tetrahydro-1-naphthalenol; (±)-8-Hydroxy-2-(dipropylamino)tetralin(±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin | 78950-78-4 | C16H25NO | 247.19 | (±)-7-(Dipropylamino)-5,6,7,8-tetrahydro-1-naphthalenol; (±)-8-Hydroxy-2-(dipropylamino)tetralin(±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin
|
| Olaparib | 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; AZD 2281; KU 0059436; KU 59436; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine; | 763113-22-0 | C24H23FN4O3 | 434.46 | 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; AZD 2281; KU 0059436; KU 59436; 1-(Cyclopropylcarb... |
| Olaparib-d4 | 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone-d4; AZD 2281-d4; KU 0059436-d4; KU 59436-d4; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine-d4; | Unlabelled: 763113-22-0 | C24H19F4D4FN4O3 | 438.49 | 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone-d4; AZD 2281-d4; KU 0059436-d4; KU 59436-d4; 1-(Cyc... |
| Olaquindox | N-(2-Hydroxyethyl)-3-methyl-2-quinoxalinecarboxamide 1,4-Dioxide; Bayernox; BayoNox; Bisergon; Fedan; NSC 634933; | 23696-28-8 | C12H13N3O4 | 263.25 | N-(2-Hydroxyethyl)-3-methyl-2-quinoxalinecarboxamide 1,4-Dioxide; Bayernox; BayoNox; Bisergon; Fedan; NSC 634933;
|
| Olaquindox-d4 | N-(2-Hydroxyethyl-d4)-3-methyl-2-quinoxalinecarboxamide 1,4-Dioxide; Bayernox-d4; BayoNox-d4; Bisergon-d4; Fedan-d4; NSC 634933-d4; | 1189487-82-8 | C12H9D4N3O4 | 267.27 | N-(2-Hydroxyethyl-d4)-3-methyl-2-quinoxalinecarboxamide 1,4-Dioxide; Bayernox-d4; BayoNox-d4; Bisergon-d4; Fedan-d4; NSC 634933-d4;
|
| Olanazpine LIP 1 Acetyl | 1-[4-(2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)-1-piperazinyl]ethanone | 935272-10-9 | C18H20N4OS | 340.44 | 1-[4-(2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)-1-piperazinyl]ethanone
|
| Okadaic Acid | (2R)-3-[(2S,6R,8S,11R)-2-[(E,1R)-3-[(2S,2&primeR,4R,4aS,6R,8aR)-4-Hydroxy-2-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-3-methylene-spiro[4a,7,8,8a-tetrahydro-4H-pyrano[2,3-e]pyran-6,5-tetrahydrofuran]-2’-yl]-1-methyl-prop-2-enyl]-11-hydroxy-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-hydroxy-2-methyl-propanoic Acid; Spiro[furan-2(3H),2(3H)-pyrano[3,2-b]pyran], acanthifolicin deriv.; 35-Demethyl-DTX 1; 35-Demethyldinophysistoxin 1; NSC 677083; OA | 78111-17-8 | C44H68O13 | 805 | (2R)-3-[(2S,6R,8S,11R)-2-[(E,1R)-3-[(2S,2&primeR,4R,4aS,6R,8aR)-4-Hydroxy-2-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]... |
Page 8150 of 10017